LINC01087 demonstrated significant upregulation (|log2 FC| ≥ 1.5, p ≤ 0.05) in 6 out of the 30 cancers as compared to their normal (i.e., non-tumor or healthy) tissue counterparts (Figure 1 and Table 1). This evidence concerns the gene LINC01087 and neoplasm.